TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $223,457 | +80.2% | 18,889 | -9.7% | 0.01% | +57.1% |
Q3 2022 | $124,000 | -80.1% | 20,914 | -55.9% | 0.01% | -53.3% |
Q2 2018 | $624,000 | -24.8% | 47,454 | -18.8% | 0.02% | -25.0% |
Q1 2018 | $830,000 | +55.7% | 58,421 | -10.1% | 0.02% | +66.7% |
Q4 2017 | $533,000 | +75.3% | 64,957 | +153.1% | 0.01% | +71.4% |
Q3 2017 | $304,000 | +17.8% | 25,662 | 0.0% | 0.01% | +16.7% |
Q2 2017 | $258,000 | – | 25,662 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |